Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 7, 2014; 20(25): 8201-8208
Published online Jul 7, 2014. doi: 10.3748/wjg.v20.i25.8201
Published online Jul 7, 2014. doi: 10.3748/wjg.v20.i25.8201
Figure 2 Kaplan-Meier curves of the survival for gastric cancer patients with DNA methyltransferase expression (Log-rank test).
A, C: No significant correlations between DNA methyltransferase 1 (DNMT1) and DNMTb expression and the overall survival time (P = 0.289, P = 0.347); B: Positive DNMT3a expression was significantly associated with poor survival in gastric cancer (P = 0.032).
- Citation: Cao XY, Ma HX, Shang YH, Jin MS, Kong F, Jia ZF, Cao DH, Wang YP, Suo J, Jiang J. DNA methyltransferase3a expression is an independent poor prognostic indicator in gastric cancer. World J Gastroenterol 2014; 20(25): 8201-8208
- URL: https://www.wjgnet.com/1007-9327/full/v20/i25/8201.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i25.8201